INTRACRANIAL MENINGIOMA
Clinical trials for INTRACRANIAL MENINGIOMA explained in plain language.
Never miss a new study
Get alerted when new INTRACRANIAL MENINGIOMA trials appear
Sign up with your email to follow new studies for INTRACRANIAL MENINGIOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Should you zap or wait? new trial tackles meningioma dilemma
Disease control Recruiting nowThis phase III trial compares radiation therapy to simple observation in patients who have had a grade II meningioma completely removed by surgery. The goal is to see if radiation helps keep the tumor from coming back. About 163 participants will be randomly assigned to either re…
Matched conditions: INTRACRANIAL MENINGIOMA
Phase: PHASE3 • Sponsor: NRG Oncology • Aim: Disease control
Last updated Jun 27, 2026 14:03 UTC
-
New drug combo targets tough brain tumors
Disease control Recruiting nowThis study tests four drugs (vismodegib, GSK2256098, capivasertib, and abemaciclib) in people with progressive meningiomas that have specific gene changes. The goal is to see if these drugs can stop tumor growth or shrink tumors. About 124 adults with confirmed mutations will rec…
Matched conditions: INTRACRANIAL MENINGIOMA
Phase: PHASE2 • Sponsor: Alliance for Clinical Trials in Oncology • Aim: Disease control
Last updated Jun 27, 2026 13:01 UTC
-
Radioactive 'Smart Bomb' targets Hard-to-Treat brain tumors
Disease control Recruiting nowThis study tests a new drug called RYZ101 for people with meningioma that has come back or is growing despite standard treatments. RYZ101 is a radioactive substance that targets a protein found on these tumor cells, aiming to kill them while sparing healthy tissue. The trial will…
Matched conditions: INTRACRANIAL MENINGIOMA
Phase: PHASE1, PHASE2 • Sponsor: Joshua Palmer • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC